FALP ( Site 5151) — Santiago, Region M. de Santiago

Public research footprint of FALP ( Site 5151), compiled from the ClinicalTrials.gov public registry.

134

Registered studies

Active

Recruiting now

Completed

Stopped or withdrawn

Most-studied conditions

Breast Neoplasms · Advanced Solid Tumors · Gallbladder Malignant Neoplasm · Non-small Cell Lung Cancer (NSCLC)

Recently updated registry entries

NCT06952504 — A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab… (Recruiting)
NCT06635824 — Trial to Evaluate Acasunlimab and Pembrolizumab Combination Superiority Over Standard of… (Active Not Recruiting)
NCT07744477 — Validation of Serum Metabolite Differences in Patients With Gallstones and Gallbladder… (Completed)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at FALP ( Site 5151)?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 05, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.